JAK2 and acquired polycythemia vera: Most PV patients (approximately 95%) carry a somatic mutation in exon 14 of a non-receptor tyrosine kinase-coding gene Janus kinase 2 (JAK2), c.1849G > T (p.Val617Phe, subsequently referred to as JAK2V617F) [5–8].